Sign In
Buy CURE
$118.52
-2.08 (-1.72%)
At Close: Jul 31, 2026
Healthcare Venture Capital Will Continue to Fuel M&A Activity
03:54pm, Thursday, 12'th Dec 2019
Merger and acquisitions (M&A;) activity within the healthcare industry heightened last year, according to recent research data and this could feed into gains for M&A; and healthcare-focused ETFs for t
5 Top-Performing Leveraged ETFs of November
05:05pm, Monday, 02'nd Dec 2019
Inside the best five best leveraged ETFs of November.
Best Leveraged ETF Areas of Last Week
01:00pm, Monday, 04'th Nov 2019
These leveraged ETFs posted solid gains last week.
CURE: Best Leveraged-Long ETF Buy Now For NearTerm Capital Gain
12:00am, Wednesday, 04'th Sep 2019Does Biocure Technology (CNSX:CURE) Have A Healthy Balance Sheet?
04:00pm, Tuesday, 30'th Jul 2019
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Flee To Cash, Sell Your Stocks. No, Instead Reinvest In Good Ones Like CURE
12:00am, Wednesday, 05'th Jun 2019Weekly ETF Gainers / Losers (04/26/19)
08:30pm, Friday, 26'th Apr 2019
No summary available.
